Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the efficacy of platelet-rich plasma therapy for androgenetic alopecia, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma therapy (platelet-rich plasma)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Androgenic Alopecia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING